This strategic acquisition expands ERBC Group’s non-clinical research and development testing portfolio, adding in ovo models for anticancer drug development.
Baugy, France, January 18th 2023 –…
- Corporate news
- Corporate newsUI Investissement, alongside MACSF, is supporting the development of ERBC Group, specialized in non-clinical research performing the evaluation of drug candidates for pharmaceutical and biotechnology…
- EventERBC (European Research Biology Center) and our partners Oncodesign, CYNBIOSE and PharmaLex a.r.c., presented a Digital Workshop “How do we keep you in the race of COVID19 ?“ during BioFIT 2020. Did…
Corporate newsERBC, Oncodesign, Cynbiose, Aepodia and PharmaLex a.r.c. and Belgium are pleased to announce the signature of a partnering agreement to provide the biotech and pharma industry with a full-service…
Corporate newsERBC: the leading independent European Contract Research Organization (CRO), expert in Pharmacology and Toxicology The European Research Biology Center (ERBC) offers a new non-clinical full-service…
